Your browser doesn't support javascript.
loading
The HSP90 inhibitor NVP-AUY922 inhibits growth of HER2 positive and trastuzumab-resistant breast cancer cells.
Canonici, Alexandra; Qadir, Zulfiqar; Conlon, Neil T; Collins, Denis M; O'Brien, Neil A; Walsh, Naomi; Eustace, Alex J; O'Donovan, Norma; Crown, John.
Afiliação
  • Canonici A; National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, Dublin 9, Ireland.
  • Qadir Z; National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, Dublin 9, Ireland.
  • Conlon NT; National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, Dublin 9, Ireland.
  • Collins DM; National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, Dublin 9, Ireland.
  • O'Brien NA; Division of Hematology-Oncology, Department of Medicine, David Geffen School of Medicine, University of California at Los Angeles, CA, Los Angeles, USA.
  • Walsh N; National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, Dublin 9, Ireland.
  • Eustace AJ; National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, Dublin 9, Ireland. alex.eustace@dcu.ie.
  • O'Donovan N; National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, Dublin 9, Ireland.
  • Crown J; National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, Dublin 9, Ireland.
Invest New Drugs ; 36(4): 581-589, 2018 08.
Article em En | MEDLINE | ID: mdl-29396630
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Resorcinóis / Neoplasias da Mama / Receptor ErbB-2 / Proteínas de Choque Térmico HSP90 / Trastuzumab / Isoxazóis Limite: Female / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Resorcinóis / Neoplasias da Mama / Receptor ErbB-2 / Proteínas de Choque Térmico HSP90 / Trastuzumab / Isoxazóis Limite: Female / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article